Literature DB >> 16866572

Image-guided radiosurgical ablation of intra- and extra-cranial lesions.

Pantaleo Romanelli1, David W Schaal, John R Adler.   

Abstract

For decades since its introduction, stereotactic radiosurgery (SRS) was used only to treat intracranial lesions because intracranial targets could be immobilized and located relative to a rigid metal frame affixed to the patient's head. Lesions outside the head were generally not treated with SRS because it is difficult to immobilize extracranial lesions and to attach stereotactic frames elsewhere on the body. Advances in computerized image guidance and robotics allowed the development of systems, such as the CyberKnife SRS System (Accuray, Inc, Sunnyvale, CA), that could target intracranial lesions without the stereotactic frame. Enhancements have resulted in a radiation delivery system that can accurately deliver high-dose, focal radiation to lesions in the spine, chest, and abdomen, even if they move during respiration. In this review we will describe the technical features of frameless SRS systems and briefly review their application to treating intracranial and extracranial lesions, focusing in particular on spinal lesions.

Entities:  

Mesh:

Year:  2006        PMID: 16866572     DOI: 10.1177/153303460600500410

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  16 in total

Review 1.  Radiosurgery of glomus jugulare tumors: a meta-analysis.

Authors:  Zachary D Guss; Sachin Batra; Charles J Limb; Gordon Li; Michael E Sughrue; Kristin Redmond; Daniele Rigamonti; Andrew T Parsa; Steven Chang; Lawrence Kleinberg; Michael Lim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-22       Impact factor: 7.038

2.  Intracranial stereotactic radiosurgery with an adapted linear accelerator vs. robotic radiosurgery: Comparison of dosimetric treatment plan quality.

Authors:  Harald Treuer; Moritz Hoevels; Klaus Luyken; Veerle Visser-Vandewalle; Jochen Wirths; Martin Kocher; Maximilian Ruge
Journal:  Strahlenther Onkol       Date:  2014-11-22       Impact factor: 3.621

3.  Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma.

Authors:  Koji Kawaguchi; Kengo Sato; Akihisa Horie; Susumu Iketani; Hiroyuki Yamada; Yasunori Nakatani; Junichi Sato; Yoshiki Hamada
Journal:  Radiat Oncol       Date:  2010-06-09       Impact factor: 3.481

4.  Stereotactic body radiotherapy for organ-confined prostate cancer.

Authors:  Alan J Katz; Michael Santoro; Richard Ashley; Ferdinand Diblasio; Matthew Witten
Journal:  BMC Urol       Date:  2010-02-01       Impact factor: 2.264

5.  Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study.

Authors:  Alan Katz; Josephine Kang
Journal:  Radiat Oncol       Date:  2014-01-01       Impact factor: 3.481

6.  Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.

Authors:  Alan Jay Katz; Josephine Kang
Journal:  Front Oncol       Date:  2014-10-28       Impact factor: 6.244

7.  Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.

Authors:  Alan J Katz; Michael Santoro; Fred Diblasio; Richard Ashley
Journal:  Radiat Oncol       Date:  2013-05-13       Impact factor: 3.481

8.  Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study.

Authors:  Alan Jay Katz; Josephine Kang
Journal:  Front Oncol       Date:  2014-09-02       Impact factor: 6.244

9.  Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.

Authors:  Alan Katz; Silvia C Formenti; Josephine Kang
Journal:  Front Oncol       Date:  2016-07-08       Impact factor: 6.244

10.  3D-Printing of Arteriovenous Malformations for Radiosurgical Treatment: Pushing Anatomy Understanding to Real Boundaries.

Authors:  Alfredo Conti; Antonio Pontoriero; Giuseppe Iatì; Daniele Marino; Domenico La Torre; Sergio Vinci; Antonino Germanò; Stefano Pergolizzi; Francesco Tomasello
Journal:  Cureus       Date:  2016-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.